menu search

Beigene announces first regulatory approval in australia for brukinsa® (zanubrutinib) for treatment of patients with waldenström's macroglobulinemia

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BTKi--BeiGene (NASDAQ: BGNE; hkex: 06160), a glo...

October 7, 2021, 4:06 pm

Beigene announces first regulatory approval in australia for brukinsa® (zanubrutinib) for treatment of patients with waldenström's macroglobulinemia

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BTKi--BeiGene (NASDAQ: BGNE; hkex: 06160), a glo...

October 7, 2021, 4:06 pm


Search within

Pages Search Results: